Bibliographie

Publié le 21/05/2010

Article réservé aux abonnés

1- DeFronzo RA, Lilly Lecture: the triumvirate: ß-cell, muscle, liver: collusion responsible for NIDDM. Diabetes 1988; 37: 667-87.

2- Monnier L, Colette C, Owens DR. Type 2 diabetes : a well characterized but suboptimally controled disease. Can we bridge the divide? Diabetes Metab 2008; 34: 207-16.

3- McIntyre N, Holdsworth CD, Tutner DS. New Interpretation of oral glucose tolerance. Lancet. 1964; 41: 20-21.

4- Heine RJ, Van Gaal LF, Johns D et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2005; 143: 559-69.

5- Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203.

6- Traitement du diabète de type 2: recommandation de bonne pratique. Afssaps/HAS 2006. Diabetes Metabolisme ; 32 : 643-8.

7- A. Fagot-Campagna, A. Weill, A. Paumier et al. Que retenir du bilan d’Entred 2007-2010 ? Médecine des Maladies Métaboliques, 2010 ;vol 4 ; numéro 2 : 212-218.